Skip to main content

Table 3 Association of insulin signaling measures with cerebral vessel pathologies

From: Brain insulin signaling and cerebrovascular disease in human postmortem brain

  OR, Estimate (SE, p)
Atherosclerosis Arteriolosclerosis Amyloid angiopathy
ELISA
 pS307IRS1/total IRS1 0.748, − 0.290 (0.1662, 0.081) 1.073, 0.071 (0.160, 0.658) 0.801, − 1.222 (0.163, 0.174)
 pT308AKT1/total AKT1 1.041, 0.040 (0.160, 0.803) 1.279, 0.246 (0.157, 0.118) 1.104, 0.099 (0.160, 0.537)
Immunohistochemistry
 IRS1 cells/mm2 1.280, 0.246 (0.175, 0.159) 0.794, − 0.231 (0.172, 0.179) 1.354, 0.303 (0.1683, 0.934)
Ex vivo stimulation
 IRS1 recruitment to IRβ 1.365, 0.311 (0.228, 0.171) 1.199, 0.182 (0.213, 0.403) 0.900, − 0.106 (0.229, 0.644)
 pS473AKT1 1.048, 0.048 (0.223, 0.834) 1.206, 0.187 (0.219, 0.392) 0.496, − 0.701 (0.253, 0.006)
 pT308AKT1 1.215, 0.1951 (0.220, 0.375) 1.115, 0.109 (0.216, 0.613) 0.643, − 0.442 (0.231, 0.055)
 pY1150/1151IRβ 1.353, 0.3025 (0.2293, 0.187) 1.295, 0.258 (0.222, 0.245) 0.994, − 0.006 (0.234, 0.979)
 pY960IRβ 1.117, 0.111 (0.221, 0.615) 1.337, 0.290 (0.218, 0.182) 0.573, − 0.557 (0.242, 0.021)
  1. Separate age and sex adjusted ordinal logistic regression models, for each categorical cerebral vessel pathology outcome measure (see text for methods, including categorizing vessel pathology into 3 ordinal levels); results which reach statistical significance are in bold (see methods for corrections for multiple comparisons)